A comparison of cardiovascular outcomes in postmenopausal women treated with aromatase inhibitors versus tamoxifen in breast cancer

被引：0
|
作者：
Fiorino, L. H.
Pitz, M.
机构：
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/0008-5472.SABCS13-P1-13-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-13-04
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitors
    Sestak, Ivana
    Cuzick, Jack
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 425 - 432
  • [2] Aromatase inhibitors for breast cancer in postmenopausal women
    Campos, SM
    [J]. ONCOLOGIST, 2004, 9 (02): : 126 - 136
  • [3] Tamoxifen versus aromatase inhibitors for breast cancer prevention
    Yue, W
    Wang, JP
    Li, YB
    Bocchinfuso, WP
    Korach, KS
    Devanesan, PD
    Rogan, E
    Cavalieri, E
    Santen, RJ
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (02) : 925S - 930S
  • [4] In postmenopausal women with breast cancer treated with aromatase inhibitors, denosumab reduced fractures
    Wilcken, Nicholas
    Lee, Clara Inkyung
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 163 (06)
  • [5] Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: Aromatase inhibitors versus tamoxifen
    Carpenter, R.
    [J]. EJSO, 2008, 34 (07): : 746 - 755
  • [6] Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings
    Ingle, JN
    Suman, VJ
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5): : 313 - 319
  • [7] The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer
    Alfaris, Ibrahim
    Asselah, Jamil
    Aziz, Haya
    Bouganim, Nathaniel
    Mousavi, Negareh
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2023, 25 (04) : 145 - 154
  • [8] A nationwide data on the cardiovascular protective effect of tamoxifen and aromatase inhibitor in postmenopausal women with breast cancer
    Moon, H-G
    Choi, S. H.
    Park, Y.
    Jung, J. G.
    Ju, Y. W.
    Kim, K. E.
    Kim, Y.
    Lee, E.
    Lee, H-B
    Han, W.
    Noh, D-Y
    Yoon, H-J
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [9] The Cardiovascular Risks Associated with Aromatase Inhibitors, Tamoxifen, and GnRH Agonists in Women with Breast Cancer
    Ibrahim Alfaris
    Jamil Asselah
    Haya Aziz
    Nathaniel Bouganim
    Negareh Mousavi
    [J]. Current Atherosclerosis Reports, 2023, 25 : 145 - 154
  • [10] Quality of Life of Women With Breast Cancer Treated in Adjuvant Setting With Tamoxifen or Aromatase Inhibitors
    Volovat, S.
    Apostol, D.
    Volovat, C.
    Carausu, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S379 - S379
12345